Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study
暂无分享,去创建一个
M. Kamya | J. Nankabirwa | J. Namuganga | P. Nayebare | G. Cuu | I. Bagala | T. Katairo | I. Nabende | S. Gonahasa | M. Nassali | S. Tukwasibwe | G. Dorsey | J. I. Nankabirwa | S. Kitaka | S. Kiguli | B. Greenhouse | I. Ssewanyana | M. R. Kamya | J. Briggs | S. Tukwasibwe | I. Ssewanyana
[1] M. Kibria,et al. Estimating the effects of COVID-19 on essential health services utilization in Uganda and Bangladesh using data from routine health information systems , 2023, Frontiers in public health.
[2] Charles Kabugo,et al. Effect of COVID-19 pandemic on inpatient service utilization and patient outcomes in Uganda , 2023, Scientific reports.
[3] O. Laeyendecker,et al. SARS‐CoV‐2 seroprevalence among blood donors in Uganda: 2019–2022 , 2023, Transfusion.
[4] T. Bousema,et al. Measures of malaria transmission, infection, and disease in an area bordering two districts with and without sustained indoor residual spraying of insecticide in Uganda , 2022, PloS one.
[5] P. Hotez,et al. SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis , 2022, eClinicalMedicine.
[6] C. Troeger,et al. Interventions for Maintenance of Essential Health Service Delivery during the COVID-19 Response in Uganda, between March 2020 and April 2021 , 2022, International journal of environmental research and public health.
[7] L. Podewils,et al. Epidemiology and Transmission Dynamics of COVID-19 in an Urban Pediatric US Population , 2022, Public health reports.
[8] A. Kirubarajan,et al. Socioeconomic and immigration status and COVID-19 testing in Toronto, Ontario: retrospective cross-sectional study , 2022, BMC Public Health.
[9] C. John,et al. Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection , 2022, medRxiv.
[10] S. Teichmann,et al. Local and systemic responses to SARS-CoV-2 infection in children and adults , 2021, Nature.
[11] G. Dorsey,et al. Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis , 2021, Malaria journal.
[12] R. Wanyenze,et al. Unintended socio-economic and health consequences of COVID-19 among slum dwellers in Kampala, Uganda , 2021, BMC Public Health.
[13] A. Kaminga,et al. Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis , 2021, Reviews in medical virology.
[14] J. Nkengasong,et al. Understanding COVID-19 in Africa , 2021, Nature Reviews Immunology.
[15] A. Josephson,et al. Socioeconomic impacts of COVID-19 in low-income countries , 2021, Nature Human Behaviour.
[16] J. Nkengasong,et al. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study , 2021, The Lancet.
[17] 12,et al. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay , 2021, medRxiv.
[18] Manish M Patel,et al. Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years — Mississippi, September–November 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[19] E. Hod,et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum , 2020, Nature Immunology.
[20] R. Viner,et al. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. , 2020, JAMA pediatrics.
[21] Jiahui Li,et al. Comparative Analysis of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children. , 2020, Annals of the Academy of Medicine, Singapore.
[22] Otto O. Yang,et al. Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 , 2020, The New England journal of medicine.
[23] J. Nkengasong,et al. COVID-19 in Africa: the spread and response , 2020, Nature Medicine.
[24] A. Flahault,et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.
[25] Wenjun Liu,et al. COVID‐19 epidemic: Disease characteristics in children , 2020, Journal of medical virology.
[26] J. Ludvigsson. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.
[27] G. Wong,et al. SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.
[28] C. Drakeley,et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. , 2019, Wellcome open research.
[29] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[30] Megan Holstein,et al. Website , 2019, iPhone App Design for Entrepreneurs.